• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Greater Canal Efficiency. Less Waste. Introducing ZenSeal(TM) Pro with ZenSave(TM) Tips from Kerr Dental

    4/16/26 2:30:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care
    Get the next $NVST alert in real time by email

    BREA, CA / ACCESS Newswire / April 16, 2026 / Kerr Dental announced the launch of NEW ZenSeal Pro with ZenSave Tips, an innovative advancement in bioceramic (BC) sealer delivery, engineered to help clinicians treat more canals with every syringe, while maintaining the high performance and clinical confidence they expect.

    Building on the trusted performance of ZenSeal™ Plus BC sealer, ZenSeal Pro takes efficiency and handling even further-so if you love ZenSeal, you'll love ZenSeal Pro even more.

    Featuring the low-waste ZenSave Tips, ZenSeal Pro reduces material waste by 33.5% compared to other high-flow bioceramic sealers, enabling practices to maximize value without compromising obturation quality or technique flexibility.

    Meet ZenSave: The Low-Waste Tip Designed for Efficiency and Access
    ZenSave Tips are designed to help clinicians retrieve more value from every 1.5 g syringe-while improving access in complex anatomies. The flexible, trimmable tip design allows clinicians to better navigate canals and deliver material where it's needed most.

    ZenSeal Pro with ZenSave Tips can be used on an average of 57 canals per syringe, compared with approximately 48 canals from other syringes, delivering meaningful efficiency gains across procedures. For practices switching from the comparator system, this may represent over $1,500 in annual savings.

    "ZenSeal Pro with ZenSave Tips gives me confidence that more of the sealer is reaching the canal rather than staying in the tip," said Dr. Rico Short, Endodontist. "In challenging anatomies, the flexibility and trimmability of the ZenSave Tips, combined with the sealer's flow and radiopacity, allow me to work efficiently while staying in control of the obturation outcome."

    A Single-Sealer Solution for Any Technique
    ZenSeal Pro is engineered as an all-in-one sealer compatible with a wide range of obturation techniques-including single-cone, cold lateral, warm vertical, and carrier-based workflows. Design verification and heat-compatibility testing demonstrate that ZenSeal Pro maintains performance under warm vertical obturation conditions, supporting advanced clinical protocols.

    Engineered for Superior Flow and Material Performance
    ZenSeal Pro's calcium silicate-based formulation delivers enhanced flowability, supporting smooth, controlled placement into canals-even in challenging cases.

    With a pH greater than 11, ZenSeal Pro creates an alkaline environment unfavorable to bacterial survival, consistent with published literature. Its optimized flow and radiopacity support precise placement, visibility, and predictable setting behavior.

    "ZenSeal Pro with ZenSave Tips reflects our focus on turning real clinician insight into purposeful innovation," said Wyatt Hanson, VP, Product Portfolio & Marketing. "Through the integration of advanced material science and a smarter delivery design, ZenSeal Pro enables greater procedural efficiency without compromising clinical performance. This launch underscores our ongoing commitment to workflow-driven innovation that moves endodontics forward."

    Learn more or Request a Demo: https://go.kerrdental.com/zensealpro?utm_medium=referral&utm_source=pr

    About Kerr Dental
    For 135 years, Kerr has been a trusted partner to the dental community, delivering innovative solutions that support modern restorative dentistry and endodontics. Founded in 1891, Kerr has built a legacy of innovation grounded in close collaboration with dental professionals, developing products designed to improve clinical workflow, efficiency, and patient outcomes.

    Kerr's comprehensive portfolio spans restorative and endodontic solutions inspired by real‑world clinical needs and supported through education, technical training, and a global network of partners. Known worldwide for integrity and reliability, the Kerr name is synonymous with quality in dentistry.

    Kerr Dental is an operating company of Envista Holdings Corporation. Envista is a global family of more than 30 trusted dental brands.
    https://www.kerrdental.com/en-us

    Kerr Dental
    200 South Kraemer Boulevard Brea, CA
    92612

    Contact:
    Kat Witt
    Marketing Specialist
    [email protected]

    SOURCE: Kerr Dental



    View the original press release on ACCESS Newswire

    Get the next $NVST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NVST

    DatePrice TargetRatingAnalyst
    4/15/2026$29.00Neutral
    Citigroup
    2/6/2026$35.00Market Perform → Outperform
    Leerink Partners
    12/9/2025$24.00Overweight
    Barclays
    5/27/2025$23.00Neutral → Outperform
    Robert W. Baird
    12/4/2024$20.00Underperform
    Mizuho
    10/31/2024$16.00 → $23.00Underperform → Market Perform
    Leerink Partners
    10/8/2024$20.00Equal Weight
    Wells Fargo
    8/8/2024$23.00 → $16.00Overweight → Neutral
    JP Morgan
    More analyst ratings

    $NVST
    SEC Filings

    View All

    SEC Form DEFA14A filed by Envista Holdings Corporation

    DEFA14A - Envista Holdings Corp (0001757073) (Filer)

    4/7/26 4:19:16 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by Envista Holdings Corporation

    DEF 14A - Envista Holdings Corp (0001757073) (Filer)

    4/7/26 4:17:29 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Envista Holdings Corporation

    SCHEDULE 13G/A - Envista Holdings Corp (0001757073) (Subject)

    3/26/26 6:22:52 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on Envista with a new price target

    Citigroup initiated coverage of Envista with a rating of Neutral and set a new price target of $29.00

    4/15/26 8:08:24 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded Envista from Market Perform to Outperform and set a new price target of $35.00

    2/6/26 8:05:48 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Barclays initiated coverage on Envista with a new price target

    Barclays initiated coverage of Envista with a rating of Overweight and set a new price target of $24.00

    12/9/25 8:46:01 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Envista Schedules First Quarter 2026 Earnings Call

    BREA, Calif., April 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its first quarter 2026 on Wednesday, May 6, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can

    4/8/26 4:10:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista Reports Fourth Quarter 2025 Results

    BREA, Calif., Feb. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended December 31, 2025. "With our disciplined focus on Growth, Operations, and People, Q4 2025 marked another quarter of continued progress for Envista," said Paul Keel, CEO.  "We delivered 10.8% core revenue growth and 22% adjusted EBITDA growth in Q425, and 6.5% core revenue growth and 26% EBITDA growth for the full-year 2025.  In the process, we posted positive growth in all major businesses and geographies, made broad-based improvements in employee d

    2/5/26 4:05:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista Schedules Fourth Quarter 2025 Earnings Call

    BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y

    1/8/26 4:20:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Keel Paul A bought $506,100 worth of shares (30,000 units at $16.87), increasing direct ownership by 8% to 402,605 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    8/14/24 4:40:20 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Hammes Eric D. bought $400,608 worth of shares (24,532 units at $16.33) (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    8/13/24 6:01:10 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Conley Eric bought $50,015 worth of shares (2,185 units at $22.89), increasing direct ownership by 5% to 47,376 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    11/20/23 5:49:32 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Nance Mark E covered exercise/tax liability with 3,368 shares and was granted 12,675 shares, increasing direct ownership by 13% to 81,252 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    2/27/26 4:19:22 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SVP, Strategy & Bus. Dev. Reis Mischa covered exercise/tax liability with 2,976 shares and was granted 5,915 shares, increasing direct ownership by 9% to 35,321 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    2/27/26 4:19:29 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Chief Executive Officer Keel Paul A covered exercise/tax liability with 11,840 shares and was granted 48,670 shares, increasing direct ownership by 11% to 384,385 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    2/27/26 4:19:10 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Financials

    Live finance-specific insights

    View All

    Envista Schedules First Quarter 2026 Earnings Call

    BREA, Calif., April 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its first quarter 2026 on Wednesday, May 6, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can

    4/8/26 4:10:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista Reports Fourth Quarter 2025 Results

    BREA, Calif., Feb. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended December 31, 2025. "With our disciplined focus on Growth, Operations, and People, Q4 2025 marked another quarter of continued progress for Envista," said Paul Keel, CEO.  "We delivered 10.8% core revenue growth and 22% adjusted EBITDA growth in Q425, and 6.5% core revenue growth and 26% EBITDA growth for the full-year 2025.  In the process, we posted positive growth in all major businesses and geographies, made broad-based improvements in employee d

    2/5/26 4:05:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista Schedules Fourth Quarter 2025 Earnings Call

    BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y

    1/8/26 4:20:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Leadership Updates

    Live Leadership Updates

    View All

    QuidelOrtho Announces Appointment of Two Independent Directors to its Board

    Veteran Healthcare CEOs John R. Chiminski and R. Scott Huennekens Bring Deep Industry Experience, Operational Expertise and Financial Acumen to the QuidelOrtho Board QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the appointments of John R. Chiminski and R. Scott Huennekens to its board of directors (the "Board"), effective December 6, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210769572/en/R. Scott Huennekens (Photo: Business Wire) T

    12/10/24 7:00:00 AM ET
    $CTLT
    $HYPR
    $NVST
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    Compass Diversified Announces Stephen Keller as Chief Financial Officer

    WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to facilitate a seamless transition. In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. He b

    8/26/24 6:00:00 AM ET
    $AVY
    $CODI
    $NVST
    Containers/Packaging
    Consumer Discretionary
    Home Furnishings
    Medical/Dental Instruments

    Envista Holdings Corporation Announces Key Leadership Appointments

    BREA, Calif., July 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the following key leadership appointments: Eric Hammes joins Envista as Chief Financial OfficerStefan Nilsson joins Envista as President, Nobel BiocareVeronica Acurio joins Envista as President, Ormco"It is a pleasure to welcome this trio of successful leaders to Envista," said Paul Keel, Chief Executive Officer. "Each brings experience in dental along with a proven track record of continuous improvement, leading with purpose, and creating value for all stakeholders. Today's an

    7/15/24 4:10:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Envista Holdings Corporation

    SC 13G - Envista Holdings Corp (0001757073) (Subject)

    11/8/24 12:09:03 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Envista Holdings Corporation (Amendment)

    SC 13G/A - Envista Holdings Corp (0001757073) (Subject)

    2/15/24 10:19:33 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Envista Holdings Corporation

    SC 13G - Envista Holdings Corp (0001757073) (Subject)

    2/14/24 4:08:38 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care